Cellectis S.A.
CMVLFOTCHealthcare
$3.47
+$0.39(+12.66%)
Market Cap$250969485
P/E Ratio—
52W High$5.04
52W Low$1.25
Cellectis S.A. (CMVLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CMVLF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $75.92M | $41.51M | $0.76M | $19.17M | $73.95M |
| Cost of Revenue | $20.88M | $0.00M | $0.74M | $1.77M | $36.27M |
| Gross Profit | $55.04M | $41.51M | $0.02M | $17.40M | $37.67M |
| Gross Margin %(computed) | 72.50% | 100.00% | 2.38% | 90.76% | 50.95% |
| Operating Expenses | |||||
| R&D Expenses | $97.32M | $90.54M | $87.65M | $97.50M | $86.95M |
| G&A Expenses | $0.00M | $17.60M | $16.81M | $17.49M | $37.87M |
| Total Operating Expenses | $97.04M | $101.06M | $90.00M | $107.06M | $123.11M |
| Operating Income | ($42.00M) | ($59.55M) | ($108.86M) | ($89.67M) | ($85.44M) |
| Operating Margin %(computed) | -55.32% | -143.48% | — | -467.72% | -115.54% |
| Interest Income | $9.88M | $11.28M | $3.69M | $1.14M | $0.74M |
| Interest Expense | $8.44M | $7.45M | $6.56M | $16.63M | $5.34M |
| Income Before Tax | ($77.70M) | ($36.76M) | ($116.47M) | ($98.60M) | ($97.48M) |
| Income Tax Expense | ($7.35M) | $0.00M | $0.37M | $0.09M | ($11.20M) |
| Net Income | ($70.34M) | ($36.76M) | ($103.17M) | ($106.14M) | ($81.07M) |
| Net Margin %(computed) | -92.66% | -88.57% | — | -553.64% | -109.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.70 | $-0.41 | $-1.77 | $-2.33 | $-1.81 |
| Wtd Avg Shares | 100.28M | 90.57M | 57.01M | 45.55M | 44.82M |
| EBITDA | ($21.12M) | ($15.16M) | ($92.64M) | ($76.38M) | ($83.15M) |
| EBITDA Margin %(computed) | -27.82% | -36.52% | — | -398.40% | -112.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Cellectis S.A. data
About Cellectis S.A. (CMVLF) Income Statement
Cellectis S.A. (CMVLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CMVLF reported revenue of $0.08B, gross profit of $0.06B (gross margin 72.50%), and net income of ($0.07B) — a net profit margin of -92.66%.
Frequently asked questions
CMVLF · 4 questionsCellectis S.A. (CMVLF) reported revenue of $0.08B for 2025, up 82.9% year-over-year.
CMVLF revenueCMVLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09